When portfolio companies start talking to each other, value compounds faster than capital.

Large exits for AI companies pushed up investor returns in January, but sub-billion-dollar IPOs are on the rise as well.

Gubra Ventures will be headed by Zoë Johnson, a former founder and biotech researcher.

January 2026 was marked by large fundraising rounds and the launch of several healthcare funds.

Emma Johnson moves from an investment role at British Business Bank to be a part of the biotech investment team at M Ventures.

After working at two pharma CVCs, Hamzeh Abdul Hadi has joined Angelini Ventures as a health tech investor in Dubai.

The new corporate venture fund will be led by Sanjeev Gupta, chief information and transformation officer at HBF Health.

With more than $37bn invested across 444 deals, January 2026 saw corporates deploy more venture money than in almost any month in the past two years.

Europe has strong life sciences research and lower costs, but still has a funding gap for early-stage companies, says Alexis Vandier, who is heading the French pharma company's new fund.

Ceili Cascarano will lead global investments and acquisitions.